DE69736241D1 - Neurotrophischer ziliarischer faktor mit geändertem aktivitätsbereich gegenüber dem wildtyp-molekül - Google Patents

Neurotrophischer ziliarischer faktor mit geändertem aktivitätsbereich gegenüber dem wildtyp-molekül

Info

Publication number
DE69736241D1
DE69736241D1 DE69736241T DE69736241T DE69736241D1 DE 69736241 D1 DE69736241 D1 DE 69736241D1 DE 69736241 T DE69736241 T DE 69736241T DE 69736241 T DE69736241 T DE 69736241T DE 69736241 D1 DE69736241 D1 DE 69736241D1
Authority
DE
Germany
Prior art keywords
factor
wild type
activity area
area against
type molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69736241T
Other languages
English (en)
Other versions
DE69736241T2 (de
Inventor
Ralph Laufer
Marco Annalise Di
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Application granted granted Critical
Publication of DE69736241D1 publication Critical patent/DE69736241D1/de
Publication of DE69736241T2 publication Critical patent/DE69736241T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69736241T 1996-07-10 1997-07-10 Humaner neurotropher ciliarer Faktor mit geändertem Aktivitätsbereich gegenüber dem des Wildtyp-Moleküls Expired - Lifetime DE69736241T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM960492 1996-07-10
IT96RM000492A IT1284867B1 (it) 1996-07-10 1996-07-10 Varianti del fattore neurotrofico ciliare umano (hcntf) con uno spettro di azione differente dalla molecola di tipo selvatico
PCT/IT1997/000163 WO1998001149A2 (en) 1996-07-10 1997-07-10 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE

Publications (2)

Publication Number Publication Date
DE69736241D1 true DE69736241D1 (de) 2006-08-10
DE69736241T2 DE69736241T2 (de) 2007-05-31

Family

ID=11404333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69736241T Expired - Lifetime DE69736241T2 (de) 1996-07-10 1997-07-10 Humaner neurotropher ciliarer Faktor mit geändertem Aktivitätsbereich gegenüber dem des Wildtyp-Moleküls

Country Status (11)

Country Link
US (1) US6756357B1 (de)
EP (1) EP0936919B1 (de)
JP (1) JP3329826B2 (de)
AT (1) ATE331734T1 (de)
AU (1) AU719086B2 (de)
CA (1) CA2260296C (de)
DE (1) DE69736241T2 (de)
ES (1) ES2265653T3 (de)
IL (1) IL127959A0 (de)
IT (1) IT1284867B1 (de)
WO (1) WO1998001149A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288388B1 (it) * 1996-11-19 1998-09-22 Angeletti P Ist Richerche Bio Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
IT1291114B1 (it) 1997-03-20 1998-12-29 Angeletti P Ist Richerche Bio Varianti del fattore neurotrofico ciliare (cntf) con migliorata selettivita' al recettore, e metodo per la loro selezione
AU2017370653B2 (en) * 2016-12-06 2022-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same
WO2018128745A1 (en) * 2017-01-06 2018-07-12 The Board Of Trustees Of The Leland Stanford Junior University Ciliary neurotrophic factor receptor ligands and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349056A (en) * 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors
EP0749980A4 (de) * 1993-12-29 1999-09-29 Sumitomo Pharma Neuartiger ziliarfaktor aus mensch
GB9413316D0 (en) * 1994-07-01 1994-08-24 Cancer Res Campaign Tech Novel proteins

Also Published As

Publication number Publication date
EP0936919A2 (de) 1999-08-25
ES2265653T3 (es) 2007-02-16
JP2000507271A (ja) 2000-06-13
CA2260296A1 (en) 1998-01-15
DE69736241T2 (de) 2007-05-31
AU719086B2 (en) 2000-05-04
CA2260296C (en) 2006-05-16
IT1284867B1 (it) 1998-05-22
ATE331734T1 (de) 2006-07-15
ITRM960492A0 (de) 1996-07-10
JP3329826B2 (ja) 2002-09-30
IL127959A0 (en) 1999-11-30
WO1998001149A3 (en) 1998-04-23
EP0936919B1 (de) 2006-06-28
ITRM960492A1 (it) 1998-01-10
AU3557697A (en) 1998-02-02
WO1998001149A2 (en) 1998-01-15
US6756357B1 (en) 2004-06-29

Similar Documents

Publication Publication Date Title
ATE281840T1 (de) Behandlung von diarrhoe
DE69333775D1 (de) Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
ATE301459T1 (de) Norbornen- und norbornandiolen zur behandlung von pigmentierungsstörungen, neurodegenerativen erkrankungen oder proliferativen hauterkrankungen
PT822829E (pt) Utilizacao do factor neurotrofico da glia (gdnf) para o tratamento de desordens da audicao
DE69525177T2 (de) Neurotrophe peptide des aktivitätsabhängigen neurotrophen faktors
UY25263A1 (es) 6-derivados sustitutivos del ácido micofenólico.-
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
DE69228997T2 (de) Menschliche il-3-varianten
EA200100342A1 (ru) Связывающие соединения адгезионной молекулы нервной клетки
DE69736241D1 (de) Neurotrophischer ziliarischer faktor mit geändertem aktivitätsbereich gegenüber dem wildtyp-molekül
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE69334087D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
ATE297942T1 (de) Kurzes peptid zur behandlung neurodegenerativer erkrankungen
ATE274054T1 (de) Ndf-peptide
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
MX9603483A (es) Acido micofenolico 6-sustituido y derivados.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition